Q4 2022 Holdings
Filed 2023-02-14 | 4 holdings | $432.4K | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2023-11-08) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $123.8M | 3,490,457 | 10.8% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $121.1M | 1,064,446 | 10.6% |
| Natera Inc(NTRA) | COM | 632307104 | $107.9M | 2,685,959 | 9.5% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $77.7M | 1,603,348 | 6.8% |
| GSK PLC(GSK)CallA | SPONSORED AD | 37733W204 | $73.6M | 2,093,700 | 6.4% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $64.7M | 232,787 | 5.7% |
| Danaher Corporation(DHR) | COM | 235851102 | $43.2M | 162,571 | 3.8% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $43.0M | 4,712,597 | 3.8% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $41.2M | 1,620,713 | 3.6% |
| Biogen Inc(BIIB) | COM | 09062X103 | $38.0M | 137,348 | 3.3% |
| Catalent Inc(CTLTEUR) | COM | 148806102 | $31.1M | 691,677 | 2.7% |
| Illumina Inc(ILMN) | COM | 452327109 | $28.3M | 140,067 | 2.5% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $24.9M | 558,774 | 2.2% |
| Envista Holdings Corporation(NVST) | COM | 29415F104 | $21.6M | 642,405 | 1.9% |
| GSK PLC | CALL | 37733W904 | $19.8M | 20,937 | 1.8% |
| Spdr SER TR(XBI) | S&P BIOTECH | 78464A870 | $17.9M | 216,087 | 1.6% |
| Centene Corp del(CNC) | COM | 15135B101 | $17.6M | 214,561 | 1.5% |
| Haleon PLC(HLN) | SPON ADS | 405552100 | $15.1M | 1,881,470 | 1.3% |
| Elevance Health Inc | COM | 036752903 | $14.4M | 28,042 | 1.3% |
| Icon PLC(ICLR) | SHS | G4705A100 | $13.0M | 66,693 | 1.1% |
| Avantor Inc(AVTR) | COM | 05352A100 | $12.7M | 600,200 | 1.1% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $12.4M | 254,586 | 1.1% |
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $12.3M | 2,200,999 | 1.1% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $10.9M | 275,704 | 1.0% |
| Humana Inc(HUM) | COM | 444859102 | $10.7M | 20,911 | 0.9% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $10.1M | 880,487 | 0.9% |
| Repligen Corp(RGEN) | COM | 759916109 | $9.7M | 57,004 | 0.8% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $9.1M | 240,975 | 0.8% |
| Model N Inc(MODNEUR) | COM | 607525102 | $8.8M | 217,880 | 0.8% |
| Community Health SYS Inc New(CYH) | COM | 203668108 | $8.6M | 2,001,994 | 0.8% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $8.6M | 178,453 | 0.7% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $8.2M | 1,290,913 | 0.7% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $8.0M | 154,796 | 0.7% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $8.0M | 411,308 | 0.7% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $7.5M | 350,747 | 0.7% |
| Spdr SER TR(XBI)CallA | S&P BIOTECH | 78464A870 | $7.5M | 90,000 | 0.7% |
| Taro Pharmaceutical Inds LTD | SHS | M8737E108 | $6.5M | 225,462 | 0.6% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $6.4M | 1,507,663 | 0.6% |
| Merck & Co Inc(MRK)CallA | COM | 58933Y105 | $5.4M | 48,700 | 0.5% |
| Evolus Inc(EOLS) | COM | 30052C107 | $5.4M | 713,774 | 0.5% |
| Incyte Corp(INCY) | COM | 45337C102 | $5.1M | 63,996 | 0.5% |
| Merck & Co Inc | CALL | 58933Y905 | $4.8M | 487 | 0.4% |
| Spdr SER TR | CALL | 78464A900 | $4.3M | 900 | 0.4% |
| Guardant Health Inc(GH) | COM | 40131M109 | $4.0M | 146,129 | 0.3% |
| Amarin Corp PLC | SPONS ADR NEW | 023111906 | $4.0M | 3,284,114 | 0.3% |
| Merus N V | COM | N5749R100 | $2.9M | 184,556 | 0.3% |
| Aerovate Therapeutics Inc | COM | 008064107 | $2.7M | 91,252 | 0.2% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $2.7M | 137,423 | 0.2% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $2.6M | 282,874 | 0.2% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $2.6M | 185,595 | 0.2% |